DE69231465D1 - Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten - Google Patents

Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten

Info

Publication number
DE69231465D1
DE69231465D1 DE69231465T DE69231465T DE69231465D1 DE 69231465 D1 DE69231465 D1 DE 69231465D1 DE 69231465 T DE69231465 T DE 69231465T DE 69231465 T DE69231465 T DE 69231465T DE 69231465 D1 DE69231465 D1 DE 69231465D1
Authority
DE
Germany
Prior art keywords
composition
diseases
treating herpes
herpes
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69231465T
Other languages
English (en)
Other versions
DE69231465T2 (de
Inventor
L Kline
W Mcalhaney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIGNAL COORDINATING THERAPY INC., PENDLETON, S, US
Original Assignee
Molecular Rx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Rx Inc filed Critical Molecular Rx Inc
Application granted granted Critical
Publication of DE69231465D1 publication Critical patent/DE69231465D1/de
Publication of DE69231465T2 publication Critical patent/DE69231465T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE69231465T 1991-04-09 1992-04-06 Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten Expired - Lifetime DE69231465T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68207191A 1991-04-09 1991-04-09
US86054692A 1992-04-03 1992-04-03
PCT/US1992/002745 WO1992018158A1 (en) 1991-04-09 1992-04-06 Method and composition for the treatment of herpes related disorders

Publications (2)

Publication Number Publication Date
DE69231465D1 true DE69231465D1 (de) 2000-10-26
DE69231465T2 DE69231465T2 (de) 2001-04-19

Family

ID=27102809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231465T Expired - Lifetime DE69231465T2 (de) 1991-04-09 1992-04-06 Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten

Country Status (15)

Country Link
US (2) US5558863A (de)
EP (1) EP0579765B1 (de)
JP (1) JP3266254B2 (de)
AT (1) ATE196424T1 (de)
AU (1) AU662152B2 (de)
BR (1) BR9205877A (de)
CA (1) CA2108135C (de)
DE (1) DE69231465T2 (de)
DK (1) DK0579765T3 (de)
ES (1) ES2151489T3 (de)
GR (1) GR3035004T3 (de)
IE (1) IE921141A1 (de)
IL (1) IL101540A (de)
NO (1) NO313489B1 (de)
WO (1) WO1992018158A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1272211E (pt) * 2000-04-07 2007-09-14 Signal Coordinating Therapy In Métodos e composições papa tratar neoplasmas
JP5414366B2 (ja) * 2009-05-29 2014-02-12 独立行政法人科学技術振興機構 疼痛治療剤
EP2900259B1 (de) * 2012-09-28 2020-04-15 Kline, Ellis Glycosidase-dosierungsplan zur behandlung von infektionserkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68088B (de) * 1978-02-16 1981-10-30 Science Union & Cie
JPS575916A (en) * 1980-06-13 1982-01-12 Teijin Ltd Polyester fiber with soft touch and production of knitted and woven fabrics therefrom

Also Published As

Publication number Publication date
EP0579765A4 (en) 1994-08-24
DE69231465T2 (de) 2001-04-19
WO1992018158A1 (en) 1992-10-29
NO933628D0 (no) 1993-10-08
US5558863A (en) 1996-09-24
ES2151489T3 (es) 2001-01-01
NO313489B1 (no) 2002-10-14
IL101540A0 (en) 1992-12-30
IL101540A (en) 1996-10-31
JP3266254B2 (ja) 2002-03-18
EP0579765B1 (de) 2000-09-20
IE921141A1 (en) 1992-10-21
CA2108135C (en) 2008-03-11
EP0579765A1 (de) 1994-01-26
AU662152B2 (en) 1995-08-24
JPH06506698A (ja) 1994-07-28
DK0579765T3 (da) 2000-10-09
NO933628L (no) 1993-12-08
US5736133A (en) 1998-04-07
CA2108135A1 (en) 1992-10-10
BR9205877A (pt) 1994-09-27
AU1926492A (en) 1992-11-17
GR3035004T3 (en) 2001-03-30
ATE196424T1 (de) 2000-10-15

Similar Documents

Publication Publication Date Title
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
DE3884200D1 (de) Verfahren zur Behandlung von Mastitis und anderen Staphylokokkeninfektionen.
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69730214D1 (de) Zusammensetzung und verfahren zur behandlung von herpes simplex
ES2159287T3 (es) Peptidos hemorreguladores.
ATE196424T1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DK82892D0 (da) Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
EE9600190A (et) Farmatseutiline kompositsioon viirusinfektsioonide ja võimalike kaasnevate põletike vältimiseks ja/või raviks ning nimetatud haiguste ravimeetod
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
DE3883754D1 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
TR199800850T2 (xx) Kan� d�zenleyici bile�imler.
ATE81454T1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.
ATE56878T1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von virus-infektionen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIGNAL COORDINATING THERAPY INC., PENDLETON, S, US

R071 Expiry of right

Ref document number: 579765

Country of ref document: EP